quinazolines has been researched along with betadex in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eijsman, L; van Wezel, HB; van Zwieten, PA; Visser, CA; Vroom, MB | 1 |
Chen, X; Resh, MD | 1 |
Fu, X; Liao, Y; Liu, H; Liu, Y; Ma, C; Zhong, J | 1 |
Boerner, JL; Bohin, N; Ge, Y; Irwin, ME; Mueller, KL | 1 |
Blanco, G; Jansson, K; Nguyen, AN; Reif, GA; Sánchez, G; Sharma, M; Wallace, DP | 1 |
Hu, X; Huang, Y; Lee, RJ; Li, H; Xiang, G; Yung, B; Zhou, X | 1 |
Alemi, F; Bunnett, NW; Canals, M; Corvera, CU; Cottrell, GS; Godfrey, CB; Jensen, DD; Kocan, M; Korbmacher, C; Lambert, NA; Murphy, JE; Niklas, C; Poole, DP | 1 |
Cui, W; Feng, B; Li, H; Liu, L; Liu, M; Shi, Y; Su, C; Su, R; Zhao, L | 1 |
Feng, J; Lei, TT; Liu, HM; Zhang, JQ; Zhang, X | 1 |
Abbas, A; Basak, S; Bhattacharya, P; Deep Punetha, V; Dey, S; Gopal Sahoo, N; Mondal, S; Saha, A | 1 |
1 trial(s) available for quinazolines and betadex
Article | Year |
---|---|
Hemodynamic effects of the novel selective cAMP-phosphodiesterase III inhibitor R 80122 in anesthetized patients with moderate left ventricular dysfunction before coronary artery bypass grafting.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Aged; Anesthesia, General; beta-Cyclodextrins; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Cyclodextrins; Echocardiography, Transesophageal; Female; Half-Life; Heart Rate; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Phosphodiesterase Inhibitors; Premedication; Prospective Studies; Pulmonary Wedge Pressure; Quinazolines; Safety; Solvents; Ventricular Dysfunction, Left | 1995 |
9 other study(ies) available for quinazolines and betadex
Article | Year |
---|---|
Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; beta-Cyclodextrins; Blotting, Western; Cell Membrane; Cholesterol; COS Cells; Cross-Linking Reagents; Culture Media, Serum-Free; Cyclodextrins; Dimerization; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Immunoblotting; Isoenzymes; Ligands; Mass Spectrometry; Membrane Microdomains; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Binding; Proteins; Quinazolines; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Type C Phospholipases; Tyrosine; Tyrphostins | 2002 |
Chiral separation of raltitrexed by cyclodextrin-modified micellar electrokinetic chromatography.
Topics: beta-Cyclodextrins; Chromatography, Micellar Electrokinetic Capillary; Electrochemistry; Electrolytes; Hydrogen-Ion Concentration; Molecular Conformation; Quinazolines; Sodium Dodecyl Sulfate; Stereoisomerism; Temperature; Thiophenes; Time Factors | 2009 |
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Topics: Atorvastatin; Benzylamines; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heptanoic Acids; Humans; Lovastatin; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Thiophenes | 2011 |
Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
Topics: beta-Cyclodextrins; Caveolin 1; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Inhibitors; ErbB Receptors; Humans; MAP Kinase Kinase Kinases; Ouabain; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-fyn; Pyrimidines; Quinazolines; Signal Transduction; Sodium-Potassium-Exchanging ATPase; src-Family Kinases; Tyrphostins | 2011 |
Novel liposomal gefitinib (L-GEF) formulations.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Stability; Gefitinib; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred ICR; Particle Size; Quinazolines | 2012 |
The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
Topics: Antineoplastic Agents; Arrestins; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; beta-Cyclodextrins; Cholagogues and Choleretics; Cyclic AMP; Deoxycholic Acid; Endocytosis; Endosomes; Enzyme Inhibitors; ErbB Receptors; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 5; HEK293 Cells; Humans; Membrane Microdomains; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oleanolic Acid; Phenylalanine; Protein Transport; Quinazolines; Receptors, G-Protein-Coupled; Thiophenes; Tyrphostins | 2013 |
Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Autophagy; beta-Cyclodextrins; Cell Survival; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gefitinib; HeLa Cells; Humans; Molecular Targeted Therapy; Nanoparticles; Quinazolines; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared | 2014 |
[A preliminary study of pharmacokinetics of evodiamine hydroxypropyl-β-cyclodextrin inclusion complex].
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Biological Availability; Chromatography, High Pressure Liquid; Quinazolines; Rats; Rats, Sprague-Dawley; Solubility | 2016 |
Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; beta-Cyclodextrins; Biological Availability; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gefitinib; Male; Mice; Molecular Docking Simulation; Quinazolines; Rats, Wistar; Simvastatin; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |